Episode Details

Back to Episodes
Apple Hit with Rare Sell Rating, J&J's Ketamine-Derived Nasal Spray Gets FDA Approved for Depression

Apple Hit with Rare Sell Rating, J&J's Ketamine-Derived Nasal Spray Gets FDA Approved for Depression

Published 1 year, 1 month ago
Description

Stock market update for January 21, 2025.


Check out our Instagram account @TheRundownDaily



Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us